Patent EP0183350A2 successfully refreshed from Google Patents.
← Back to Patent Explorer
EP0183350A2 Expired / Lapsed EP ⏱️ 0.0 years remaining

DNA Encoding human colony stimulating factor, peptide encoded thereby,vectors and transformed hosts containing such DNA, and the production of all thereof

Assignee: Immunex Corp
•
Filing: 1985-09-25
•
Granted: —
•
Expires: 2005-09-25
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A chemically-synthesized oligonucleotide composing a portion of the nucleotide sequence of the murine GM-CSF may be employed as a probe to isolate the gene coding for murine GM-CSF. The murine GM-CSF gene may be selected from a murine cDNA library prepared from RNA produced by mitogen-stimulated LBRM-33 splenic lymphoma cells. Double-stranded cDNA may be prepared from polyadenylated RNA extracted from human cells thought to produce human CM-CSF. Such cDNA is insertable within a plasmid vector and the recombinant plasmid employed to transform hosts. Plasmid DNA, prepared from pools of the transformed hosts, may be hybridized with a probe composed of a large portion of the coding sequence of the murine GM-CSF cDNA gene. Pools of host cells that provide a positive signal to the murine cDNA probe may be identified, subdivided, and rescreened until a single positive colony is identified. Human plasmid cDNA can be prepared from this colony, and the human GM-CSF gene sequenced. The coding region of the gene may be inserted into an expression vector for expression of functional human GM-CSF.

Inventors

  • 👤 Dirk M Anderson
  • 👤 Michael A Cantrell
  • 👤 Douglas P Cerretti
  • 👤 David J Cosman
  • 👤 Alf D Larsen
  • 👤 Virginia L Price

Bibliographic Details

Application Number —
Jurisdiction EP
Data Source google_patents
Last Synchronized 2026-10-24 04:20
CPC Classifications
C; C12; C12N; C12N15/00; C12N15/09; C12N15/63; C12N15/79; C12N15/80; C12N15/81; C07; C07K; C07K14/00; C07K14/435; C07K14/52; C07K14/53; C07K14/535

Claims Analysis

Total Claims: 15
Claim 1
Independent Claim 13 words
Substantially pure DNA that encodes for the expression of human colony stimulating factor.
Claim 2
Dependent Claim 13 words
Substantially pure DNA that encodes for the expression of human colony stimulating factor.
Claim 3
Dependent Claim 28 words
DNA as claimed in Claim 1 and having the nucleic acid sequence extending from nucleic acid base No. 14 to nucleic acid base No. 394 in FIGURE 2.
Claim 4
Dependent Claim 31 words
DNA as claimed in Claim 1 or Claim 2 and coding for the amino acid sequence extending from amino acid residue No. to amino acid residue No. 127 in FIGURE 2.
Claim 5
Dependent Claim 27 words
DNA as claimed in any one of Claims 1 to 3 and encoding for the expression of human colony stimulating factor molecules in prokaryotie or eukaryotic hosts.
Claim 6
Dependent Claim 21 words
An amino acid chain encoded by DNA of nucleic acid sequence as defined in any one of Claims 1 to 3.
Claim 7
Dependent Claim 33 words
A recombinant DNA vector comprising a cDNA sequence comprising the gene for human granulocyte-macrophage colony stimulating factor and optionally further defined by the specific features of any one of Claims 2 or 3.
Claim 8
Dependent Claim 36 words
A recombinant DNA vector as Claimed in Claim 6, comprising an expression vector having the promoter and leader sequence for the yeast mating pheromone a -factor to promote efficient synthesis of human granulocyte-macrophage colony stimulating factor.
Claim 9
Dependent Claim 13 words
A host transformed by a vector as claimed in Claim 6 or 7.
Claim 10
Dependent Claim 31 words
Homogeneous granulocyte-macrophage colony stimulating factor comprising a polypeptide backbone comprising the amino acid sequence Extending from amino acid residue No. 1 to amino acid residue No. 127 inclusive in FIGURE 2.
Claim 11
Dependent Claim 31 words
Homogeneous granulocyte-macrophage colony stimulating factor comprising a polypeptide backbone comprising the amino acid sequence Extending from amino acid residue No. 1 to amino acid residue No. 127 inclusive in FIGURE 2.
Claim 12
Dependent Claim 132 words
A process for preparing DNA encoding at least part of the human colony stimulating factor molecule or DNA as defined in any one of Claims 1 to 4 and including the steps of isolating polyadenylated mRNA from cells capable of producing colony stimulating factor, preparing a library of cDNA corresponding to the isolated mRNA. cloning the resulting cDNA by inserting it within a cloning vector, using the resultant cloning vector to transform host cells, identifying resultant transformants containing plasmid DNA encoding part at least of the colony stimulating factor molecule by hybridization using an oligonucleotide probe corresponding to a portion of the colony stimulating factor gene, and optionally expressing active colony stimulating factor by inserting the resulting cDNA in an expression vector and using the resulting expression vector to transform host cells.
Claim 13
Dependent Claim 76 words
A process for producing a vector for the expression of a colony stimulating factor peptide including the step of inserting DNA as defined in any one of Claims 1-4 into a starting vector under the control of a control sequence so as to be expressable in a host for the vector, said starting vector optionally having the promotor and leader sequence for yeast mating pheromone -factor to promote efficient synthesis of human granulocyte-macrophage colony stimulating factor.
Claim 14
Dependent Claim 42 words
A process for producing a transformant capable of expressing a colony stimulating factor peptide comprising transforming a host with a vector produced in accordance with Claim 10 or Claim 11 or with a vector as claimed in Claim 6 or Claim 7.
Claim 15
Dependent Claim 40 words
A process for producing a human colony stimulating factor peptide comprising growing a transformant as claimed in Claim 8 or which has been produced by a process as claimed in Claim 12 and allowing it phenotypically to express its genotype.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Maintenance schedule is calculated for granted US utility patents.

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag